Table 4 Differences in the expression of TC PD-L1 and LAG-3 among the molecular subtypes of breast cancer
| Â | Negative | Positive | OR (95% CI) | P-value |
|---|---|---|---|---|
TC PD-L1 | 268 | 29 | Â | |
Luminal A | 103 (38.4) | 3 (10.3) | 0.18 (0.03, 0.63) | 0.027 |
Luminal B | 104 (38.8) | 11 (37.9) | 0.95 (0.39, 2.23) | 0.90 |
HER2-enriched | 25 (9.3) | 7 (24.1) | 3.10 (1.12, 8.4) | 0.014 |
TNBC | 36 (13.4) | 8 (27.6) | 2.43 (1.02, 6.2) | 0.043 |
LAG-3 | 108 | 172 | Â | |
Luminal A | 52 (48.1) | 51 (29.7) | 0.49 (0.29, 0.83) | 0.047 |
Luminal B | 30 (27.8) | 77 (44.8) | 1.97 (1.16, 3.39) | 0.007 |
HER2-enriched | 11 (10.2) | 18 (10.5) | 0.47 (0.17, 1.28) | 0.97 |
TNBC | 15 (13.9) | 26 (15.1) | 0.30 (0.11, 0.77) | 0.87 |